Aurisco Pharmaceutical Co.,Ltd. (605116.SS)
CNY 20.8
(-0.48%)
CNY 20.8
(-0.48%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 509.79 Million CNY | 14.58% |
| 2022 | 444.93 Million CNY | 36.15% |
| 2021 | 326.79 Million CNY | 37.43% |
| 2020 | 237.79 Million CNY | -1.0% |
| 2019 | 240.2 Million CNY | 5.38% |
| 2018 | 227.93 Million CNY | 21.26% |
| 2017 | 187.97 Million CNY | -7.71% |
| 2016 | 203.67 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 513.92 Million CNY | 0.81% |
| 2024 Q3 | 581.47 Million CNY | 4.94% |
| 2024 Q2 | 554.08 Million CNY | 7.81% |
| 2023 Q3 | 494.49 Million CNY | -0.8% |
| 2023 FY | 509.79 Million CNY | 14.58% |
| 2023 Q2 | 498.45 Million CNY | 13.08% |
| 2023 Q1 | 440.8 Million CNY | -0.93% |
| 2023 Q4 | 509.79 Million CNY | 3.1% |
| 2022 Q4 | 444.93 Million CNY | 13.08% |
| 2022 Q3 | 393.47 Million CNY | 7.28% |
| 2022 Q2 | 366.76 Million CNY | 0.84% |
| 2022 Q1 | 363.72 Million CNY | 11.3% |
| 2022 FY | 444.93 Million CNY | 36.15% |
| 2021 Q3 | 285.67 Million CNY | 6.39% |
| 2021 Q1 | 257.46 Million CNY | 8.27% |
| 2021 Q4 | 326.79 Million CNY | 14.4% |
| 2021 FY | 326.79 Million CNY | 37.43% |
| 2021 Q2 | 268.52 Million CNY | 4.3% |
| 2020 Q4 | 237.79 Million CNY | 1.15% |
| 2020 FY | 237.79 Million CNY | -1.0% |
| 2020 Q3 | 235.08 Million CNY | -0.8% |
| 2020 Q2 | 236.96 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q2 | 236.41 Million CNY | 0.0% |
| 2019 Q4 | 240.2 Million CNY | 0.0% |
| 2019 FY | 240.2 Million CNY | 5.38% |
| 2018 FY | 227.93 Million CNY | 21.26% |
| 2017 FY | 187.97 Million CNY | -7.71% |
| 2016 FY | 203.67 Million CNY | 0.0% |